Research study Program year 2024 Source: CMS Open Payments

Xp-8121-120

Research payments

$1,289,218

58 payments

Through program year 2024, $1,289,218 in research payments was reported against Xp-8121-120, across 58 payments, paid by Xeris Pharmaceuticals, Inc..

Paid by: Xeris Pharmaceuticals, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2024	Research	$477,729	25
2023	Research	$811,489	33

Breakdown

Who paid Research payments · program years 2023–2024

Xeris Pharmaceuticals, Inc. $1,289,218 58 payments

Who received the money Research payments · program years 2023–2024

Panax Clinical Research Organisation paid for research $355,534 13 payments
ProSciento Inc. Organisation paid for research $268,308 10 payments
American Research Corporation Organisation paid for research $218,233 6 payments
Catalina Research Institute Organisation paid for research $213,870 18 payments
Rainer Clinical Research Center Organisation paid for research $208,659 7 payments
Mt. Olumpus Medical Research Center Organisation paid for research $24,614 4 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

7 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.